Skip to main content
Clinical Trials/NCT04890678
NCT04890678CompletedNot Applicable

The Use of a Fully Automated Pulsating Support System (CuroCell® A4 CX20) in Pressure Ulcer Prevention and Treatment: a Clinical Test in 10 Belgian Nursing Homes

University Ghent1 site in 1 country40 target enrollmentStarted: February 20, 2019Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
40
Locations
1
Primary Endpoint
Pressure ulcer healing

Study Overview

Brief Summary

Pressure Ulcers are a serious and common problem for residents admitted to long-term care facilities and community care patients. They represent a major burden to patients, carers and the Healthcare system, affecting approximately 1 in 20 community patients. International guidelines recommend the use of pressure redistribution support surfaces, systematic patient repositioning and preventive skin care to prevent pressure ulcers.

It has been acknowledged that a significant proportion of pressure ulcers are avoidable. The prevalence of pressure ulcers is 1 of the 4 common harms recorded in the UK NHS Safety Thermometer, a local improvement tool for measuring, monitoring and analyzing patient harms across a range of settings, including nursing homes, community nursing and hospitals on a monthly basis.

Study Design

Study Type
Interventional
Allocation
Non Randomized
Intervention Model
Single Group
Primary Purpose
Supportive Care
Masking
None

Eligibility Criteria

Ages
65 Years to 110 Years (Older Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • •At risk of pressure ulcer development based on a Braden score ≤ 17 or pressure ulcer category III or IV
  • •Bedbound or chair bound
  • •Aged ≥ 65

Exclusion Criteria

  • •Short-stay residents (expected length of stay ≤14 days)
  • •End of life care
  • •Medical contraindication for patient repositioning/turning

Arms & Interventions

22 residentsat risk for PU development

Experimental

22 residents at risk for PU development, defined by a Braden score < 12 and/or a Braden subscale 'Mobility' score ≤ 2 and/or the presence of non-blanchable erythema in the sacral area.

aged 65 years or over

Intervention: 22 residentsat risk for PU development (Device)

18 residents at least one PU category III-IV in the sacral area

Experimental

18 residents at least one PU category III-IV in the sacral area aged 65 years or over

Intervention: 18 residents at least one PU category III-IV in the sacral area (Device)

Outcomes

Primary Outcomes

Pressure ulcer healing

Time Frame: 30 days

Healing of pressure ulcers category III and IV during the 30-day study period - using the Pressure Ulcer Scale for Healing Tool (PUSH)

Pressure ulcer incidence

Time Frame: 30 days

Development of at least 1 Pressure ulcer category II+ during study period using European Pressure Ulcer Advisory Panel (EPUAP) classification system

Secondary Outcomes

  • Comfort(30 days)

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials